SCANPHARM A/S: Financial statements 2015
CVR: 16279099
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 20,446,816 and a net result of DKK 715,522 compared with DKK 431,209 the year before. That is a decrease of 1.6% compared with the year before. Equity in the 2015 report amounted to DKK 11,704,517. The solvency ratio was 37.6%. The company had 42 employees in the financial year.
- Gross Profit
- DKK 20,446,816
- Profit/Loss
- DKK 715,522
- Equity
- DKK 11,704,517
- Total Assets
- DKK 31,126,089
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 20.4 mio. | 716 t. | 11.7 mio. | 42 |
| 2014 | - | 20.8 mio. | 431 t. | 11 mio. | - |
| 2013 | - | 20.9 mio. | 400 t. | 10.6 mio. | - |
Official annual report
How creditworthy is SCANPHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
SCANPHARM A/S has published its annual report for 2014. Gross profit came to DKK 20,769,828, and the net result was DKK 431,209.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees (2018). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.